ENTRAR            

En la actualidad, son numerosos los estudios desarrollados con objeto de verificar la existencia de una relación entre la obesidad y ciertos tipos de cáncer. Teniendo en cuenta la elevada prevalencia de ambas cosas y de su elevado impacto social, es importante profundizar en su etiología, con objeto de identificar una posible relación causa-efecto entre ambos procesos. Numerosas investigaciones han intentado establecer una asociación entre ambos procesos, circunstancia que aún continúa en entredicho. Después de la menopausia, los ovarios dejan de producir estrógenos, por lo que el tejido adiposo se convierte en la principal fuente de esa hormona. Así pues, aquellos tejidos que, como el parénquima mamario, son muy sensibles [seguir leyendo].
 

Bibliografía

1. Remesar X, Rafecas I, Alemany M, Fernández López JÁ. La obesidad ¿factor de riesgo para el cáncer? Nutrición y Obesidad 2000; 3: 194-01.
2. Bray George. The underlying basis for obesity: relationship to cancer. The Journal of Nutrition 2002; 132: 3451S-455S
3. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362 (9382): 419-27.
4. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95 (16): 1218-226.
5. [Not authors listed]. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996; 347 (9017): 1713-727.
6. [Not authors listed]. Breast cancer and hormona replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350 (9084): 1047-59.
7. M.ª J. Aguilar Cordero, E. González Jiménez, A. P. García López, J. Álvarez Ferré, C. A. Padilla López, R. Guisado Barrilao y M. Rizo Baeza
8. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr 2005; 147: 753-60.
9. Rubin C, Maisonet M, Kieszak S, Monteilh C, Holmes A, Flanders D, Heron J, Golding J, McGeehin M, Marcus M. Timing of maturation andpredictors of menarche in girls enrolled in a contemporary British cohort. Paediatr Perinat Epidemiol  2009; 23: 492-504.
10. Hines LM, Risendal B, Slattery ML, Baumgartner KB, Giuliano AR, Sweeney C, Rollison DE, Byers T. Comparative Analysis of Breast Cancer Risk Factors Among Hispanic and Non-Hispanic White Women. Cancer 2010; 1: 3215- 223.
11. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2001; 2:133-140.
12. Duncan AM: The role of nutrition in the prevention of breast cancer. AACN Clinical Issues 2004; 15:119-135.
13. Forman MR, Hursting SD, Umar A, Barret JC: Nutrition and cancer prevention. Annu Rev Nutr 2004; 24:223-54.
14. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15:617-631.
15. Willett WC: Diet and cancer: one view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 2001; 10:3-8.
16. Bartsch H, Nair J, Owen RW: Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emergin evidence for their role as risk modifiers. Carcinogénesis 1999; 20:2209-2218.
17. Carroll KK: Dietary fats and cancer. Am J Clin Nutr 1991; 53:1064S-1067S.
18. Birt DF, Kris ES, Choe M, Pelling JC: Dietary energy and fat effects on tumor promotion. Cancer Res 1992; 52:2035S-2039S.
19. Solanas M, Hurtado A, Costa I, Moral R, Menéndez JA, Colomer R, Escrich E: Effects of high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet. Int J Oncol 2002; 21:745-753.
20. Bartsch H, Nair J, Owen RW: Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem 2002; 383:915-921.
21. Escrich E, Solanas M, Moral R: Olive oil, and other dietary lipids, in cancer: experimental approaches. En: Olive oil and Health (JL Quiles, MC Ramírez-Tortosa & P Yaqoob) 2006; CABI Publishing. pp. 317-374.
22. Tannenbaum A: The genesis and growth of tumors. III Effects of a high fat diet. Cancer Research 1942; 2:468-475.
23. Kaizer L, Boyd NF, Kriukov V, Tritchler D: Fish consumptionand breast cancer risk: and ecological study. Nutr Cancer 1989; 12:61-68.
24. Menéndez JA, Vellón L, Colomer R, Lupu R: Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her- 2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/ neuoncogene amplification. Ann Oncol 2005; 16:359-371.
25. Quiles JL, Huertas J, Wahle KWJ, Battino M, Mataix J: Aceite de oliva y cáncer. En: Aceite de oliva y salud (Mataix). Universidad de Granada y Puleva Food.2001; pp. 155-188.
26. Sasaki S, Horacsek M, Kesteloot H: An ecological study of the relationship between dietary fat intake and breast cancer mortality. Prev Med 1993; 22:187 202.
27. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A: Dietary long chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004; 79: 935-45.
28. Maillard V, Bougoux P, Ferrari P y cols.: n-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer 2002; 98:78-83.
29. Augustsson K, Michaud DS, Rimm EB y cols.: A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:64-7.
30. Terry P, Wolk A, Vainio H, Weiderpass E: Fatty fish consumption lowers the risk of endometrial cancer: a nationwide case control study in Sweden. Cancer Epidemiol Biomarkers Prev 2002; 11:143-145.
31. Bosetti C, Negri E, Franceschi S y cols.: Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001; 93:911-915.
32. Rose DP, Connolly JM: Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999; 83:217-44.
33. Field CJ, Schley PD: Evidence for potential mechanisms for the effect ofof conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am J Clin Nutr 2004; 79:1190S-8S.
34. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002; 132:2995-2998
36. Bingham SA, Luben R, Welch A, Wareman N, Khaw KT, Day N: Are imprecise methods obscuring a relation between fat and breast cancer. Lancet 2003; 362:212-214.
36. Cho E, Spieglman D, Hunter DJ, Chen WY, Stampfer MJ, Coldtitz GA, Willet WC: Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 2003; 95:1079-1085.
37. Byrne C, Rockett H, Holmes MD: Dietary fat, fat subtypes, and breast cancer risk: lack of an association among potmenopausal women with no history of being breast disease. Cancer Epidemiol Biomarkers Prev 2002; 11:261-265.
38. Do MH, Lee SS, Jung PJ, Lee MH: Intake of dietary fat and vitamin in correlation to breast cancer risk in Korean women: a case control study. J Korean Med Sci 2003; 18:534-540.
39. Martín-Moreno JM, Willet WC, Gorgojo L y cols.: Dietary fat, olive oil intake and breast cancer risk. Int J Cancer 1994; 58:774-780.
40. La Vechia C, Negri E, Franceschi S, Decarli A, Giacosa A, Lipworth L: Olive oil, other dietary fats, and the risk of breastcancer (Italy). Cancer Causes and Control 1995; 6:545-550.
41. Trichopoulou A, Katsouyanni K, Stuver S y cols.: Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 1995; 87:110-116.
42. Goodstine SL, Zheng T, Holford TR, Ward BA, Carter D, Owens PH, Mayne ST: Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not to post-menopausal breast cancer risk in US women. J Nutr 2003; 133:1409-1414.
43. Doll R, Peto R. The causes of cancer: quantitative estimates of advoidable risk of cancer in the United States. J Natl Cancer Instit 1981; 66: 1191-1308.
44. Peto R, López AD, Borehan J, Thun M, Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-1278.
45. Doll R, Peto R,Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 year´s observation on male British doctors. BMJ 1994; 309: 901-11.127.
46. López AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developing counties.Tobacco control 1994; 3: 242-247.
47. Borràs JM, Borràs J, Viladiu P, Bosch X, editores. Epidemiologia i prevenció del càncer a Catalunya, 1975-1992. Barcelona: Institut Català d´Oncologia, 1997.
48. Miller AB, Berrino F, Hill M, Pietinen E, Riboli E, Wahrendorf. Diet in the aetiology of cancer: a review. Eur J Cancer 1994; 30: 207-220.
49. Austoker J, Muir G. Prevention of cancer. En: Fowler G, Gray M, Anderson P, editores. Prevention in general practice. Oxford General Practice Series 23 (2.a ed.). Oxford: Oxford University Press, 1993.
50. Silagy C, Stead LF. Physician advice for smoking cessation (Cochrane Review). En: The Cochrane Library, Issue 3. 2001; Oxford: Update Software.

error on connection